Juniper Therapeutics
Preqin (labeled Juniper Therapeutics in firmographics) is a BlackRock-owned alternative assets data and analytics platform serving 200,000+ institutional professionals with proprietary coverage of 67,000+ firms and 235,000+ funds across private markets.
- Company typePrivate
- Founded2003
- HeadquartersSingapore, Singapore
- Headcount1,001–5,000
- GTM typeB2B
- OfferingSoftware
What Juniper Therapeutics does
The input data describes Preqin (labeled in firmographics as Juniper Therapeutics, a Singapore-based osteoarthritis treatment company founded in 2003; however all substantive source passages pertain exclusively to Preqin and its products, with explicit confirmation that no information about Juniper Therapeutics was found in the source passages). Preqin is an alternative assets data and analytics platform, now part of BlackRock, that has collected private markets data for over 20 years. Its flagship Preqin Pro platform serves 200,000+ professionals across private equity, venture capital, private credit, real estate, infrastructure, hedge funds, natural resources, and secondaries, covering 67,000+ firms, 235,000+ funds, and a $5.4tn transaction repository. Data collection combines automated ingestion (regulatory filings, press releases, websites) with direct human relationships to GPs and LPs, and is delivered via web platform, API, FTP/SFTP data feeds, and partner platform integrations (Dealcloud, JuniperSquare, Backstop Solutions, Hebbia, Dynamo Software).
The product portfolio spans Preqin Pro (core platform), Private Markets Research / Insights+ (Global Reports series), Term Intelligence (LPA benchmarking), Benchmarks and Indices, Preqin Sustainability (ESG), Company Intelligence, Transaction Intelligence, Enterprise Data Solutions, plus educational and community products (Preqin Academy, First Close newsletter, Awards). Pricing is negotiated via Order Forms based on licensed teams and scope, with annual auto-renewals and CPI-linked escalators; a freemium free-account tier feeds top-of-funnel conversion.
The business model is enterprise subscription-led with a freemium lead-generation layer and a secondary data broker/PI monetization stream. Primary customer segments are Fund Managers (GPs) and Investors (LPs) — pension funds, sovereign wealth funds, insurance companies, family offices, endowments — with secondary segments including Investment Consultants, Banks, Placement Agents, Service Providers, Advisory firms, Academic Institutions, and Industry Associations. HQ is registered in London (1st Floor, Verde, 10 Bressenden Place, London SW1E 5DH, United Kingdom), with global processing centers across Europe, USA, India, Philippines, and Singapore, and parent company BlackRock headquartered in New York.
Juniper Therapeutics firmographics
Firmographics- Name
- Juniper Therapeutics
- Website
- https://preqin.com
- Company type
- Private
- Founded year
- 2003
- Headcount range
- 1,001–5,000 employees
- Short description
- Preqin (labeled Juniper Therapeutics in firmographics) is a BlackRock-owned alternative assets data and analytics platform serving 200,000+ institutional professionals with proprietary coverage of 67,000+ firms and 235,000+ funds across private markets.
- Ownership category
- akta.pro rank
Juniper Therapeutics industry classification
Industry- Product category
- Alternative Assets Data Analytics
- NAICS
- Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394), Computer Systems Design and Related Services (54151)
- SIC
- Services-Engineering, Accounting, Research, Management (8700), Investment Advice (6282)
- akta.pro primary industry
- Alternative Data & Credit Scoring (Cashflow, Telco, Utility, Open Banking) (FSAGAHAC)
- akta.pro secondary industries
- Credit Monitoring, Portfolio Analytics & Early Warning Systems (FSAGAHAJ), Lead Generation, Comparison & Marketplace Platforms (Financial Products) (FSAEAMAM)
Keywords
Where Juniper Therapeutics is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices1 record
Markets served
Juniper Therapeutics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Subscription Licensing (Preqin Pro / Insights+): Preqin operates primarily on a subscription model. Clients (fund managers, investors, consultants, banks, placement agents, etc.) pay subscription fees for access to the Preqin Pro platform, data, and Insights+ research reports. Pricing is based on team size, licensed teams, and the scope of data access (Order Form specifies team size, name, function, divisions and locations of Users). Subscriptions auto-renew annually with CPI-linked price increases unless terminated with 30 days notice. Preqin also offers subscription access to Preqin Insights+ for exclusive reports and studies.
- Enterprise Data Solutions (API & Data Feeds): Enterprise clients integrate Preqin data via APIs, data feeds, and partner platform integrations (e.g., CRM platforms, Dealcloud, JuniperSquare, Backstop Solutions, Hebbia). This is a B2B data licensing revenue stream with pricing based on breadth and depth of data integration, potentially incurring incremental costs depending on the partner platform.
- Insights+ Subscription (Reports & Studies): Exclusive subscription service providing access to the Preqin Global Reports series (Private Equity, Venture Capital, Private Credit, Real Estate, Infrastructure in 2026), research library, webinar recordings, and analyst content. Users may create New Materials incorporating up to 10% limited extracts for internal business purposes, citing 'Source: Preqin, a part of BlackRock'.
- Data Broker / PI Sales: Preqin sells certain Personal Information (Identification data, Contact data, and Professional Information data) to its customers who subscribe to certain databases for their own purposes, including marketing. Preqin is registered as a data broker under Texas law. This is classified as a data monetisation stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free Account — limited data access with basic Preqin Profiles and research library access |
| Subscription | Annual | Preqin Pro — full platform access with comprehensive private capital and hedge fund datasets and analytics tools |
| Subscription | Annual | Insights+ — exclusive research subscription with Global Reports, publications, and analyst content |
| Subscription | Annual | Enterprise Data Solutions — API, Data Feeds, and Partner Platform integrations |
Distribution channels5 records
Marketing channels10 records
Juniper Therapeutics product offering
Product offeringCore offering
Juniper Therapeutics' provided source material describes a B2B alternative assets data and analytics platform (Preqin) that delivers comprehensive datasets, analytics tools, and research across private equity, venture capital, private credit, real estate, infrastructure, hedge funds, natural resources, and secondaries to fund managers, institutional investors, consultants, banks, and placement agents. The offering combines a flagship subscription platform (Preqin Pro) with add-on modules covering Term Intelligence, Benchmarks and Indices, ESG data, Company Intelligence, and Transaction Intelligence, plus enterprise data delivery via APIs, data feeds, and partner platform integrations, and a separate Insights+ research subscription.
Product overview
Preqin is a unified data and analytics platform for private markets, offering a core platform (Preqin Pro) with multiple integrated modules and add-on products. The core platform provides access to comprehensive alternative assets data (private equity, venture capital, private credit, real estate, infrastructure, hedge funds, natural resources, and secondaries). Add-on modules include Private Markets Research (Insights+) for exclusive reports, Term Intelligence for LPA benchmarking, Benchmarks and Indices for performance measurement, Preqin Sustainability for ESG data, Company Intelligence for deal data, Transaction Intelligence for transaction-level analysis, and Enterprise Data Solutions for API/data feed delivery. The platform also includes educational tools (Preqin Academy), compensation analysis, and a newsletter. Data is delivered via the web platform, API, data feeds, and partner platform integrations.
Differentiator
Problem solved
Functional benefit
Products and services
- Preqin Pro Flagship alternative assets data and analytics platform providing comprehensive datasets and analytics tools across private equity, venture capital, hedge funds, real estate, infrastructure, private credit, natural resources, and secondaries for fund managers, institutional investors, consultants, banks, and placement agents.
- Private Markets Research (Insights+) Subscription research service providing exclusive access to Preqin's Global Reports series (Private Equity, Venture Capital, Private Credit, Real Estate, Infrastructure), research library, webinar recordings, and analyst commentary.
- Enterprise Data Solutions Flexible enterprise data delivery via REST APIs, FTP/SFTP data feeds, and partner platform integrations enabling clients to embed Preqin data into their own systems, data warehouses, and workflows.
- Transaction Intelligence Transaction repository providing deal-level intelligence across private market transactions, including proprietary data on 47,000+ instruments and $1.7tn of invested capital across private credit.
- Term Intelligence Benchmarking tool for Limited Partnership Agreement (LPA) terms, enabling comparison of fund contractual terms such as management fees and carry structures against market standards.
- Preqin Benchmarks and Indices Performance data offering including proprietary indices, horizon IRRs, net-to-LP returns, public market equivalents (PME), and custom benchmarks for measuring private market fund performance.
- Company Intelligence Companies and deals dataset providing comprehensive coverage of private market transactions, portfolio companies, and deal flow intelligence.
- Preqin Sustainability ESG data and insights product integrating environmental, social, and governance factors into private markets workflows across asset classes.
Quantifiable outcome
- 200,000+ professionals rely on Preqin products globally
- +3 more outcomes
Companies that use Juniper Therapeutics
Customer profileNamed customers3 records
Segments9 records
Ideal customer profiles3 records
Juniper Therapeutics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability3 records
Feature11 records
Juniper Therapeutics partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered partner platform and minor / operational.
- Dynamo Softwarepartner platformDynamo Software integrates Preqin data into its platform, enabling clients to access private markets data within their existing Dynamo workflow. Preqin maintains data quality and governance while Dynamo handles native integration.
- Dealcloud (SS&C)partner platformDealcloud, an SS&C company, embeds Preqin data into its deal management and workflow platform, providing seamless access to private capital data within the deal lifecycle management system.
- JuniperSquarepartner platformJuniperSquare integrates Preqin data into its fund administration and investor management platform, providing fund managers with real-time access to private markets benchmarks and intelligence within their operational workflows.
- Backstop Solutions (SS&C)partner platformBackstop Solutions, an SS&C company, integrates Preqin data into its platform for investment management workflows, enabling users to enrich their data with private markets intelligence.
- Hebbiapartner platformHebbia integrates Preqin data into its AI-powered platform, providing enhanced private markets data within its intelligence and analysis workflows.
- NAVEX Global, Inc.minor / operationalNAVEX Global administers the Business Integrity Hotline and Business Integrity Reporting Website on behalf of BlackRock/Preqin, enabling anonymous reporting of ethics concerns, complaints, and potential illegal or unethical conduct.
Scale indicators15 records
Recent moves6 records
Expansion highlights6 records
Juniper Therapeutics competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Juniper Therapeutics social profiles
Digital presenceJuniper Therapeutics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Juniper Therapeutics leadership team
Management profileNumber of profiles
Juniper Therapeutics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Juniper Therapeutics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Juniper Therapeutics
What does Juniper Therapeutics do?
Juniper Therapeutics' provided source material describes a B2B alternative assets data and analytics platform (Preqin) that delivers comprehensive datasets, analytics tools, and research across private equity, venture capital, private credit, real estate, infrastructure, hedge funds, natural resources, and secondaries to fund managers, institutional investors, consultants, banks, and placement agents. The offering combines a flagship subscription platform (Preqin Pro) with add-on modules covering Term Intelligence, Benchmarks and Indices, ESG data, Company Intelligence, and Transaction Intelligence, plus enterprise data delivery via APIs, data feeds, and partner platform integrations, and a separate Insights+ research subscription.
When was Juniper Therapeutics founded?
Juniper Therapeutics was founded in 2003. It employs 1,001 to 5,000 people.
Where is Juniper Therapeutics based?
Juniper Therapeutics is headquartered in Singapore, Singapore, in the Asia region.
How does Juniper Therapeutics make money?
Four revenue lines are on record. Subscription Licensing (Preqin Pro / Insights+) is the primary driver. The others are enterprise Data Solutions (API & Data Feeds), insights+ Subscription (Reports & Studies) and data Broker / PI Sales.
Does Juniper Therapeutics have an API?
Yes. The Service may be provided via an Application Program Interface provided by Preqin (the API). The API is one of multiple delivery channels specified in the Order Form alongside the Website, Data Feed (via FTP, SFTP or otherwise), email newsletter, and Preqin Authorised Redistributor. The API enables clients to integrate Preqin data into their own systems and applications. Clients using the API must identify the application it will be integrated with (proprietary or third-party system) and provide details of licensed teams and Users who will access the Data. Preqin Enterprise Data Solutions also supports data delivery via API with OAuth 2.0 and Basic Authentication (username/API key) for secure access.
What industry is Juniper Therapeutics in?
Juniper Therapeutics's product category is Alternative Assets Data Analytics. Its primary akta.pro industry code is FSAGAHAC, Alternative Data & Credit Scoring (Cashflow, Telco, Utility, Open Banking), with a secondary code of FSAGAHAJ, Credit Monitoring, Portfolio Analytics & Early Warning Systems. Its NAICS code is 523940 and its SIC code is 8700.